Treatment Efficacy Of Abiraterone (Abi), Enzalutamide (Enza) Or Cabazitaxel (Caba) In Metastasic Castration-Resistant Prostate Cancer Patients (Mcrpc) After Progression To Docetaxel Plus Androgen Deprivation Therapy (Adt) In Hormone Sensible Disease.

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 1|浏览18
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要